PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 439,102 | $7,324,221 | 0.00% |
| RHUMBLINE ADVISERS | 82,809 | $1,381,239 | 0.00% |
| GOLDMAN SACHS GROUP INC | 467,203 | $7,792,946 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 1,181,256 | $19,705,847 | 0.00% |
| NORTHERN TRUST CORP | 562,688 | $9,385,635 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 831,993 | $13,879 | 0.00% |
| CITIGROUP INC | 147,828 | $2,465,771 | 0.00% |
| BARCLAYS PLC | 176,837 | $2,950 | 0.00% |
| TD ASSET MANAGEMENT INC | 110,800 | $1,848,144 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 71,059 | $1,185,264 | 0.00% |
| VANGUARD GROUP INC | 3,228,394 | $53,849,612 | 0.00% |
| VOYA INVESTMENT MANAGEMENT LLC | 42,963 | $716,623 | 0.00% |
| MORGAN STANLEY | 429,004 | $7,155,788 | 0.00% |
| FMR LLC | 509,242 | $8,494,156 | 0.00% |
| AMALGAMATED BANK | 6,761 | $113 | 0.00% |
| SEI INVESTMENTS CO | 40,216 | $670,803 | 0.00% |
| MARSHALL WACE, LLP | 21,747 | $362,740 | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 9,245 | $154,207 | 0.00% |
| Mariner, LLC | 14,542 | $242,561 | 0.00% |
| Bank of New York Mellon Corp | 201,444 | $3,360,086 | 0.00% |
External links
This page lists PROTAGONIST THERAPEUTICS INC's shareholders in Q3 2023. To view PROTAGONIST THERAPEUTICS INC's shareholder history, click here.